Abstract

Breast cancer is the most common malignant tumor among women worldwide. Although increasing evidence indicates that long noncoding RNAs (lncRNAs) play critical roles during breast tumorigenesis and progression, the involvement of most lncRNAs in breast cancer remains largely unknown. In the current study, we demonstrated that LINC00665 promotes breast cancer cell proliferation, migration, and invasion. Accumulating evidence indicates that many lncRNAs can function as endogenous miRNA sponges by competitively binding common miRNAs. In this study, we demonstrated that LINC00665 functions as a sponge for miR-379-5p, reducing the ability of miR-379-5p to repress LIN28B. LINC00665 promoted breast cancer progression and induced an epithelial–mesenchymal transition-like phenotype via the upregulation of LIN28B expression. Clinically, LINC00665 expression was increased but miR-379-5p expression was decreased in breast cancer tissues compared with that in normal breast tissues in the TCGA database. Furthermore, the expression of LINC00665 was negatively related with miR-379-5p expression. Collectively, our results reveal the LINC00665–miR-379-5p–LIN28B axis and shed light on breast cancer therapy.

Highlights

  • Breast cancer is one of the most common malignant tumor and the main cause of cancer-associated mortality in women worldwide[1]

  • Our results revealed a LINC00665–miR-379-5p–LIN28B axis involved in the regulation of epithelial–mesenchymal transition (EMT) during breast tumorigenesis and progression

  • Dysfunction of Long noncoding RNAs (lncRNAs) is associated with multiple cellular processes during tumorigenesis and progression, such as apoptosis, proliferation, invasion, migration, angiogenesis, and metastasis[15]

Read more

Summary

Introduction

Breast cancer is one of the most common malignant tumor and the main cause of cancer-associated mortality in women worldwide[1]. Earlier diagnosis and systemic therapy have improved the prognosis of breast cancer patients, recurrence, metastasis and drug resistance are barriers to the successful treatment of patients with breast cancer. Our understanding of the pathogenesis and mechanisms of breast cancer remains greatly limited. Identifying new genes and pathways involved in breast cancer will aid the development of faster and safer diagnostic methods and improve breast cancer prognosis and treatment. Over 90% of human genes can be transcribed into RNAs, but only 1–2% can encode proteins[2]. Long noncoding RNAs (lncRNAs) are a class of non-coding RNAs lncRNAs in regulation of chromatin remodeling, transcription, posttranscription, and translation[5,6,7,8]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call